EUVIMEDEUVIMED entdecken
Fallbericht

Medullary Thyroid Carcinoma That Progressed From Low‐ to High‐Grade During Treatment: A Case Report

Masaomi Sen iD, Takenori Fujii, Yukako Shintani-Domoto, Ryo Ito, Takeshi Abe, Hiroko Kazusaka, Mami Matsui, Marie Saito, Ryuta Nagaoka, Tomoo Jikuzono, Atsuko Sakanushi, Iwao Sugitani iD und 1 weitere

Pathology International · 2026

DOI: 10.1111/pin.70089 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pathology International, 2026. Verfasst von Masaomi Sen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrine Surgery, Nippon Medical School Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Carcinoma, Neuroendocrine. Die Arbeit nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Medullary thyroid carcinoma (MTC) with high proliferative potential or tumor necrosis is classified as high‐grade MTC. Progression from low‐ to high‐grade MTC has rarely been documented. We report a case in which a sporadic MTC transitioned from low‐ to high‐grade after the initial therapy. A 62‐year‐old man with low‐grade MTC underwent total thyroidectomy and bilateral neck dissection. Recurrence was identified postoperatively, and the surgical specimen of the lymph node revealed metastatic MTC with high‐grade features. Treatment was initiated with vandetanib followed by selpercatinib, with no significant efficacy. Debulking surgery was performed for five recurrent lesions. Surgical specimens of the tumor after chemotherapy showed increased aggression, characterized by high Ki‐67 index and decreased calcitonin expression. The patient eventually died due to brain metastasis. This case highlights the potential for MTC to progress from low‐ to high‐grade and underscores the importance of ongoing evaluations for recurrent disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsCarcinoma, NeuroendocrineHumansMiddle AgedMaleQuinazolinesNeoplasm Recurrence, LocalDisease ProgressionPiperidinesThyroidectomyFatal OutcomePyridinesAniline CompoundsPyrazoles

Stichwörter der Autor:innen

high‐grade medullary carcinomamulti‐kinase inhibitorrecurrenceselective RET inhibitorthyroid glandtransformation

Substanzen

QuinazolinesvandetanibPiperidinesselpercatinibPyridinesAniline CompoundsPyrazoles

Autor:innen und Institutionen

  • Department of Endocrine Surgery, Nippon Medical School Hospital, Tokyo, Japan.
  • Department of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo, Japan.
  • Department of Otolaryngology, Head and Neck Surgery, Nippon Medical School Hospital, Tokyo, Japan.

ORCID-Profile: Masaomi Sen, Iwao Sugitani

Zitieren

APA

Sen, M., Fujii, T., Shintani-Domoto, Y., Ito, R., Abe, T., Kazusaka, H., Matsui, M., Saito, M., Nagaoka, R., Jikuzono, T., Sakanushi, A., Sugitani, I., & Ohashi, R. (2026). Medullary Thyroid Carcinoma That Progressed From Low‐ to High‐Grade During Treatment: A Case Report. Pathology International. https://doi.org/10.1111/pin.70089

Vancouver

Sen M, Fujii T, Shintani-Domoto Y, Ito R, Abe T, Kazusaka H, et al. Medullary Thyroid Carcinoma That Progressed From Low‐ to High‐Grade During Treatment: A Case Report. Pathology International. 2026. doi:10.1111/pin.70089

BibTeX
@article{Sen2026,
  author = {Sen, Masaomi and Fujii, Takenori and Shintani-Domoto, Yukako and Ito, Ryo and Abe, Takeshi and Kazusaka, Hiroko and Matsui, Mami and Saito, Marie and Nagaoka, Ryuta and Jikuzono, Tomoo and Sakanushi, Atsuko and Sugitani, Iwao and Ohashi, Ryuji},
  title = {Medullary Thyroid Carcinoma That Progressed From Low‐ to High‐Grade During Treatment: A Case Report},
  journal = {Pathology International},
  year = {2026},
  doi = {10.1111/pin.70089}
}
Kostenlos starten →